(STMPA) STMicroelectronics - Overview
Exchange: PA •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000226223
Stock: Integrated Circuits, Sensors, Power Devices, Microcontrollers
Total Rating 44
Risk 84
Buy Signal -0.42
| Risk 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Relative Tail Risk | -6.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.69 |
| Alpha | 0.30 |
| Character TTM | |
|---|---|
| Beta | 1.283 |
| Beta Downside | 1.853 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.43% |
| CAGR/Max DD | -0.20 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 180.8
Description: STMPA STMicroelectronics March 04, 2026
STMicroelectronics N.V. (STMPA) designs, develops, manufactures, and sells semiconductor products globally. The companys business model involves a wide range of offerings across various segments, including Analog products, MEMS and Sensors, Power and Discrete products, Microcontrollers, and Digital ICs and RF products.
STMPAs product portfolio includes industrial ASICs, power management solutions, custom analog ICs, wireless charging, and various drivers. It also offers MEMS sensors like accelerometers, gyroscopes, and biosensors, as well as optical sensing solutions. The company provides silicon and SiC MOSFETs, IGBTs, microcontrollers, NFC solutions, and RF communication devices. The semiconductor sector is characterized by high capital expenditure for R&D and manufacturing facilities.
STMPA serves diverse markets, including automotive, industrial, personal electronics, communications equipment, and computers. The companys broad market exposure helps mitigate risks associated with reliance on a single industry. To understand the companys competitive landscape and financial performance in more detail, consider further research on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 172.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.04 > 1.0 |
| NWC/Revenue: 64.50% < 20% (prev 59.99%; Δ 4.50% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.36b > Net Income 172.8m |
| Net Debt (-704.1m) to EBITDA (2.31b): -0.30 < 3 |
| Current Ratio: 3.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (890.1m) vs 12m ago -4.87% < -2% |
| Gross Margin: 33.89% > 18% (prev 0.39%; Δ 3350 % > 0.5%) |
| Asset Turnover: 49.57% > 50% (prev 53.63%; Δ -4.06% > 0%) |
| Interest Coverage Ratio: 6.59 > 6 (EBITDA TTM 2.31b / Interest Expense TTM 69.0m) |
Altman Z'' 6.36
| A: 0.32 (Total Current Assets 11.27b - Total Current Liabilities 3.35b) / Total Assets 24.80b |
| B: 0.53 (Retained Earnings 13.08b / Total Assets 24.80b) |
| C: 0.02 (EBIT TTM 454.6m / Avg Total Assets 24.77b) |
| D: 2.31 (Book Value of Equity 15.19b / Total Liabilities 6.58b) |
| Altman-Z'' Score: 6.36 = AAA |
Beneish M -3.12
| DSRI: 0.77 (Receivables 1.75b/2.44b, Revenue 12.28b/13.27b) |
| GMI: 1.16 (GM 33.89% / 39.34%) |
| AQI: 1.16 (AQ_t 0.10 / AQ_t-1 0.09) |
| SGI: 0.93 (Revenue 12.28b / 13.27b) |
| TATA: -0.09 (NI 172.8m - CFO 2.36b) / TA 24.80b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of STMPA shares?
As of March 06, 2026, the stock is trading at EUR 28.60 with a total of 4,034,416 shares traded.
Over the past week, the price has changed by -0.90%, over one month by +16.22%, over three months by +28.07% and over the past year by +26.12%.
Over the past week, the price has changed by -0.90%, over one month by +16.22%, over three months by +28.07% and over the past year by +26.12%.
Is STMPA a buy, sell or hold?
STMicroelectronics has no consensus analysts rating.
What are the forecasts/targets for the STMPA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.2 | 2% |
| Analysts Target Price | - | - |
STMPA Fundamental Data Overview March 05, 2026
Market Cap USD = 28.04b (24.10b EUR * 1.1632 EUR.USD)
Market Cap USD = 28.04b (24.10b EUR * 1.1632 EUR.USD)
P/E Trailing = 180.8
P/E Forward = 34.8432
P/S = 2.0427
P/B = 1.6513
P/EG = 0.4669
Revenue TTM = 12.28b USD
EBIT TTM = 454.6m USD
EBITDA TTM = 2.31b USD
Long Term Debt = 1.83b USD (from longTermDebt, last quarter)
Short Term Debt = 298.0m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -704.1m USD (from netDebt column, last quarter)
Enterprise Value = 25.25b USD (28.04b + Debt 2.13b - CCE 4.92b)
Interest Coverage Ratio = 6.59 (Ebit TTM 454.6m / Interest Expense TTM 69.0m)
EV/FCF = -1000.0x (Enterprise Value 25.25b / FCF TTM -14.1m)
FCF Yield = -0.06% (FCF TTM -14.1m / Enterprise Value 25.25b)
FCF Margin = -0.11% (FCF TTM -14.1m / Revenue TTM 12.28b)
Net Margin = 1.41% (Net Income TTM 172.8m / Revenue TTM 12.28b)
Gross Margin = 33.89% ((Revenue TTM 12.28b - Cost of Revenue TTM 8.12b) / Revenue TTM)
Gross Margin QoQ = 35.05% (prev 33.23%)
Tobins Q-Ratio = 1.02 (Enterprise Value 25.25b / Total Assets 24.80b)
Interest Expense / Debt = 0.61% (Interest Expense 13.0m / Debt 2.13b)
Taxrate = 21.0% (US default 21%)
NOPAT = 359.2m (EBIT 454.6m * (1 - 21.00%))
Current Ratio = 3.36 (Total Current Assets 11.27b / Total Current Liabilities 3.35b)
Debt / Equity = 0.12 (Debt 2.13b / totalStockholderEquity, last quarter 17.83b)
Debt / EBITDA = -0.30 (Net Debt -704.1m / EBITDA 2.31b)
Debt / FCF = 50.07 (negative FCF - burning cash) (Net Debt -704.1m / FCF TTM -14.1m)
Total Stockholder Equity = 17.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.70% (Net Income 172.8m / Total Assets 24.80b)
RoE = 0.97% (Net Income TTM 172.8m / Total Stockholder Equity 17.81b)
RoCE = 2.31% (EBIT 454.6m / Capital Employed (Equity 17.81b + L.T.Debt 1.83b))
RoIC = 1.75% (NOPAT 359.2m / Invested Capital 20.55b)
WACC = 9.92% (E(28.04b)/V(30.17b) * Re(10.64%) + D(2.13b)/V(30.17b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 10.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.84%
[DCF] Fair Price = unknown (Cash Flow -14.1m)
EPS Correlation: -82.47 | EPS CAGR: -40.89% | SUE: -2.67 | # QB: 0
Revenue Correlation: -62.42 | Revenue CAGR: 2.04% | SUE: 0.96 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.21 | Chg7d=+0.003 | Chg30d=+0.031 | Revisions Net=+3 | Analysts=3
EPS current Year (2026-12-31): EPS=1.06 | Chg7d=+1.060 | Chg30d=+1.060 | Revisions Net=+6 | Growth EPS=+121.3% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=2.03 | Chg7d=+2.030 | Chg30d=+2.030 | Revisions Net=+7 | Growth EPS=+73.1% | Growth Revenue=+11.5%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.1% (Discount Rate 10.6% - Earnings Yield 0.6%)
[Growth] Growth Spread = +4.1% (Analyst 14.2% - Implied 10.1%)
Market Cap USD = 28.04b (24.10b EUR * 1.1632 EUR.USD)
P/E Trailing = 180.8
P/E Forward = 34.8432
P/S = 2.0427
P/B = 1.6513
P/EG = 0.4669
Revenue TTM = 12.28b USD
EBIT TTM = 454.6m USD
EBITDA TTM = 2.31b USD
Long Term Debt = 1.83b USD (from longTermDebt, last quarter)
Short Term Debt = 298.0m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -704.1m USD (from netDebt column, last quarter)
Enterprise Value = 25.25b USD (28.04b + Debt 2.13b - CCE 4.92b)
Interest Coverage Ratio = 6.59 (Ebit TTM 454.6m / Interest Expense TTM 69.0m)
EV/FCF = -1000.0x (Enterprise Value 25.25b / FCF TTM -14.1m)
FCF Yield = -0.06% (FCF TTM -14.1m / Enterprise Value 25.25b)
FCF Margin = -0.11% (FCF TTM -14.1m / Revenue TTM 12.28b)
Net Margin = 1.41% (Net Income TTM 172.8m / Revenue TTM 12.28b)
Gross Margin = 33.89% ((Revenue TTM 12.28b - Cost of Revenue TTM 8.12b) / Revenue TTM)
Gross Margin QoQ = 35.05% (prev 33.23%)
Tobins Q-Ratio = 1.02 (Enterprise Value 25.25b / Total Assets 24.80b)
Interest Expense / Debt = 0.61% (Interest Expense 13.0m / Debt 2.13b)
Taxrate = 21.0% (US default 21%)
NOPAT = 359.2m (EBIT 454.6m * (1 - 21.00%))
Current Ratio = 3.36 (Total Current Assets 11.27b / Total Current Liabilities 3.35b)
Debt / Equity = 0.12 (Debt 2.13b / totalStockholderEquity, last quarter 17.83b)
Debt / EBITDA = -0.30 (Net Debt -704.1m / EBITDA 2.31b)
Debt / FCF = 50.07 (negative FCF - burning cash) (Net Debt -704.1m / FCF TTM -14.1m)
Total Stockholder Equity = 17.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.70% (Net Income 172.8m / Total Assets 24.80b)
RoE = 0.97% (Net Income TTM 172.8m / Total Stockholder Equity 17.81b)
RoCE = 2.31% (EBIT 454.6m / Capital Employed (Equity 17.81b + L.T.Debt 1.83b))
RoIC = 1.75% (NOPAT 359.2m / Invested Capital 20.55b)
WACC = 9.92% (E(28.04b)/V(30.17b) * Re(10.64%) + D(2.13b)/V(30.17b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 10.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.84%
[DCF] Fair Price = unknown (Cash Flow -14.1m)
EPS Correlation: -82.47 | EPS CAGR: -40.89% | SUE: -2.67 | # QB: 0
Revenue Correlation: -62.42 | Revenue CAGR: 2.04% | SUE: 0.96 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.21 | Chg7d=+0.003 | Chg30d=+0.031 | Revisions Net=+3 | Analysts=3
EPS current Year (2026-12-31): EPS=1.06 | Chg7d=+1.060 | Chg30d=+1.060 | Revisions Net=+6 | Growth EPS=+121.3% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=2.03 | Chg7d=+2.030 | Chg30d=+2.030 | Revisions Net=+7 | Growth EPS=+73.1% | Growth Revenue=+11.5%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.1% (Discount Rate 10.6% - Earnings Yield 0.6%)
[Growth] Growth Spread = +4.1% (Analyst 14.2% - Implied 10.1%)